Thyroid Function and Cognitive Decline: A Narrative Review

Overview

Journal Endocr Pract

Specialty Endocrinology

Date 2024 Aug 7

PMID 39111592

Authors

Sophia Hemmrich Sinha

Kahli Zietlow

Maria Papaleontiou

Affiliations

Soon will be listed here.

Abstract

Objective: As the population of older adults in the United States continues to rise, understanding modifiable risk factors that contribute to cognitive decline and dementia becomes increasingly important. This narrative review summarizes existing literature on the association between thyroid function in the euthyroid range, hypothyroidism and hyperthyroidism, and cognitive outcomes in older adults.

Methods: A comprehensive literature search of the PubMed and Ovid/Medline databases was conducted. Randomized controlled trials, systematic reviews, meta-analyses, and observational studies published in English between January 2000 and December 2023 were included.

Results: Overall, existing studies yielded conflicting results, failing to delineate a concrete relationship between thyroid function and cognitive outcomes and/or dementia in older adults. There may be a possible association between higher thyroid stimulating hormone in the reference range and lower risk of incident dementia, which may be more pronounced in women. Majority of studies elucidated a possible association between low thyroid stimulating hormone and incident dementia, with suggestion that duration of hyperthyroidism may contribute to increasing dementia risk. Even though evidence on the association of hypothyroidism and cognitive decline are disparate, current data do not support treatment of subclinical hypothyroidism to improve cognitive outcomes in older adults.

Conclusion: Despite numerous studies, there is no conclusive evidence that supports a direct relationship between hyperthyroidism or hypothyroidism and cognitive decline. Study limitations include heterogeneity in study designs, measurement methodologies, and cognitive assessment tools. Future research is needed to better delineate whether an association exists and whether treatment of thyroid dysfunction ameliorates cognitive impairment.

References

Brito D, Esteves F, Rajado A, Silva N, Araujo I, Braganca J . Assessing cognitive decline in the aging brain: lessons from rodent and human studies. NPJ Aging. 2023; 9(1):23. PMC: 10587123. DOI: 10.1038/s41514-023-00120-6. View

Kalmijn S, Mehta K, Pols H, Hofman A, Drexhage H, Breteler M . Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf). 2001; 53(6):733-7. DOI: 10.1046/j.1365-2265.2000.01146.x. View

Zhang X, Wang Y, Wang H, Zhang X . Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012. J Clin Endocrinol Metab. 2023; 109(2):e657-e666. DOI: 10.1210/clinem/dgad558. View

Atzmon G, Barzilai N, Hollowell J, Surks M, Gabriely I . Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009; 94(4):1251-4. PMC: 2682478. DOI: 10.1210/jc.2008-2325. View

Ye Y, Wang Y, Li S, Guo J, Ding L, Liu M . Association of Hypothyroidism and the Risk of Cognitive Dysfunction: A Meta-Analysis. J Clin Med. 2022; 11(22). PMC: 9694203. DOI: 10.3390/jcm11226726. View

Correia N, Mullally S, Cooke G, Tun T, Phelan N, Feeney J . Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism. J Clin Endocrinol Metab. 2009; 94(10):3789-97. DOI: 10.1210/jc.2008-2702. View

Lavery L, Dodge H, Snitz B, Ganguli M . Cognitive decline and mortality in a community-based cohort: the Monongahela Valley Independent Elders Survey. J Am Geriatr Soc. 2008; 57(1):94-100. PMC: 2768614. DOI: 10.1111/j.1532-5415.2008.02052.x. View

Stott D, Rodondi N, Kearney P, Ford I, Westendorp R, Mooijaart S . Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017; 376(26):2534-2544. DOI: 10.1056/NEJMoa1603825. View

Trzepacz P, Hochstetler H, Wang S, Walker B, Saykin A . Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015; 15:107. PMC: 4562190. DOI: 10.1186/s12877-015-0103-3. View

10.

Vogel A, Elberling T, Hording M, Dock J, Rasmussen A, Feldt-Rasmussen U . Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology. 2006; 32(1):36-43. DOI: 10.1016/j.psyneuen.2006.09.012. View

11.

Tan Z, Beiser A, Vasan R, Au R, Auerbach S, Kiel D . Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med. 2008; 168(14):1514-20. PMC: 2694610. DOI: 10.1001/archinte.168.14.1514. View

12.

Mooijaart S, Du Puy R, Stott D, Kearney P, Rodondi N, Westendorp R . Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. JAMA. 2019; 322(20):1977-1986. PMC: 6822162. DOI: 10.1001/jama.2019.17274. View

13.

Thvilum M, Brandt F, Lillevang-Johansen M, Folkestad L, Brix T, Hegedus L . Increased risk of dementia in hypothyroidism: A Danish nationwide register-based study. Clin Endocrinol (Oxf). 2021; 94(6):1017-1024. DOI: 10.1111/cen.14424. View

14.

Folkestad L, Brandt F, Lillevang-Johansen M, Brix T, Hegedus L . Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts. Thyroid. 2020; 30(5):672-680. DOI: 10.1089/thy.2019.0672. View

15.

van Vliet N, van Heemst D, Almeida O, Asvold B, Aubert C, Bae J . Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis. JAMA Intern Med. 2021; 181(11):1440-1450. PMC: 8424529. DOI: 10.1001/jamainternmed.2021.5078. View

16.

Adams R, Oh E, Yasar S, Lyketsos C, Mammen J . Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults. JAMA Intern Med. 2023; 183(12):1324-1331. PMC: 10594176. DOI: 10.1001/jamainternmed.2023.5619. View

17.

Njegovan V, Hing M, Mitchell S, Molnar F . The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci. 2001; 56(10):M638-43. DOI: 10.1093/gerona/56.10.m638. View

18.

Yeap B, Alfonso H, Chubb S, Puri G, Hankey G, Flicker L . Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study. J Clin Endocrinol Metab. 2012; 97(12):E2230-7. DOI: 10.1210/jc.2012-2108. View

19.

Juarez-Cedillo T, Basurto-Acevedo L, Vega-Garcia S, Sanchez-Rodriguez Martha A, Retana-Ugalde R, Juarez-Cedillo E . Prevalence of thyroid dysfunction and its impact on cognition in older mexican adults: (SADEM study). J Endocrinol Invest. 2017; 40(9):945-952. DOI: 10.1007/s40618-017-0654-6. View

20.

Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque M . A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab. 2010; 95(8):3623-32. DOI: 10.1210/jc.2009-2571. View